You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Masked Hypertension

Showing 1 - 25 of 8,019
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Masked Hypertension With Smart Wearable Devices (SMART)

Not yet recruiting
  • Masked Hypertension
  • smart wearable device
  • Beijing, China
    Peking University People's Hospital
Jun 3, 2022

Obstructive Sleep Apnea, Masked Hypertension Trial in Lleida (CPAP treatment)

Recruiting
  • Obstructive Sleep Apnea
  • Masked Hypertension
  • CPAP treatment
  • Lleida, Spain
    Hospital Universitari Arnau de Vilanova
May 4, 2022

Prevalence of Masked Hypertension in Nephrological Patients

Recruiting
  • Masked Hypertension
  • Comparison ABPM with OBPM
  • Zurich, Switzerland
    Stadtspital Waid Zurich
Oct 27, 2021

Masked Hypertension Trial in Birmingham (Carvedilol, Amlodipine)

Withdrawn
  • Masked Hypertension
  • Birmingham, Alabama
    Hypertension Research Clinic at UAB
Oct 28, 2021

Masked Hypertension Trial in Shanghai (Allisartan Isoproxil, Placebo)

Active, not recruiting
  • Masked Hypertension
  • Allisartan Isoproxil
  • Placebo
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 27, 2021

Masked Hypertension Trial in Milan, Maracaibo (Optimization of antihypertensive treatment based on office BP, Optimization of

Recruiting
  • Masked Hypertension
  • Optimization of antihypertensive treatment based on office BP
  • Optimization of antihypertensive treatment based on 24-hour ABPM
  • Milan, Italy
  • +1 more
Jan 25, 2022

Wearable Blood Pressure Devices to Identify Masked Uncontrolled

Recruiting
  • Hypertension,Essential
  • Hypertension, Masked
    • Hsinchu, Taiwan
      National Taiwan University Hospital Hsin-chu Branch
    Apr 26, 2021

    Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

    Not yet recruiting
    • Open Angle Glaucoma
    • Ocular Hypertension
    • Travoprost Ophthalmic Topical Cream low-dose
    • +4 more
    • Newport Beach, California
      Glaukos Clinical Study Site
    Nov 22, 2023

    Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)

    Not yet recruiting
    • Glaucoma Open-Angle Primary
    • Ocular Hypertension
    • H-1337 0.6%
    • +3 more
    • Albany, Georgia
      Dixon Eye Care
    Jun 12, 2023

    Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

    Not yet recruiting
    • Primary Open Angle Glaucoma (POAG)
    • +3 more
    • Experimental: QLS-111 ophthalmic solution, (0.015%)
    • +4 more
    • (no location specified)
    Aug 30, 2023

    Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

    Completed
    Has Results
    • Glaucoma, Open-Angle
    • Hypertension, Ocular
    • NCX 470
    • Latanoprost 0.005%
    • Austin, Texas
      Texan Eye
    Nov 9, 2022

    Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

    Recruiting
    • Cataract
    • +2 more
    • Bimatoprost Implant System (High Dose)
    • +4 more
    • Glendale, Arizona
      Arizona Advanced Eye Research Institute
    Nov 8, 2023

    Ocular Hypertension Trial in Australia (FM101 tablet, FM101 oral solution, Placebo)

    Recruiting
    • Ocular Hypertension
    • FM101 tablet
    • +4 more
    • Bella Vista, New South Wales, Australia
    • +4 more
    Jul 18, 2022

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide/brimonidine ophthalmic suspension, Simbrinza

    Completed
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Brinzolamide/brimonidine ophthalmic suspension
    • Simbrinza 0.2%/1% Ophthalmic Suspension
    • Winston-Salem, North Carolina
      James D. Branch Ophthalmology
    Aug 18, 2022

    Glaucoma, Open-Angle Trial in Durham (VVN539 Ophthalmic Solution 0.02%, VVN539 Ophthalmic Solution 0.04%, VVN539 Ophthalmic

    Recruiting
    • Glaucoma, Open-Angle
    • VVN539 Ophthalmic Solution 0.02%
    • +2 more
    • Durham, North Carolina
      Lexitas
    Jul 19, 2022

    Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.065%, NCX 470 0.1%, Latanoprost 0.005%)

    Completed
    • Open Angle Glaucoma
    • Ocular Hypertension
    • NCX 470 0.065% (initial phase of trial)
    • +4 more
    • Newport Beach, California
      Eye Research Foundation
    Oct 20, 2022

    Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic

    Recruiting
    • Primary Open Angle Glaucoma
    • Ocular Hypertension
    • SBI-100 Ophthalmic Emulsion, 0.5%
    • +2 more
    • Glendale, California
    • +2 more
    Nov 17, 2023

    Glaucoma, Primary Open Angle, Ocular Hypertension Trial (TUG, Sham)

    Terminated
    • Glaucoma, Primary Open Angle
    • Ocular Hypertension
    • TUG
    • Sham
    • (no location specified)
    Mar 28, 2022

    Primary Open Angle Glaucoma, Ocular Hypertension Trial in Albany (QLS-101, Timolol Maleate)

    Completed
    • Primary Open Angle Glaucoma
    • Ocular Hypertension
    • Albany, Georgia
      Dixon Eye Care
    May 3, 2022

    Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

    Completed
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • Nebivolol Ophthalmic Suspension 1 Percent
    • +3 more
    • Newport Beach, California
      Site 0012
    Jul 18, 2022

    Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.1%, Latanoprost 0.005%)

    Recruiting
    • Open Angle Glaucoma
    • Ocular Hypertension
    • NCX 470 0.1%
    • Latanoprost 0.005%
    • Newport Beach, California
      Eye Research Foundation
    Apr 26, 2022

    Glaucoma, Open-Angle Trial in Colorado Springs (drug, other, device)

    Recruiting
    • Glaucoma, Open-Angle
    • Travoprost Intraocular Implant
    • +2 more
    • Colorado Springs, Colorado
      Glaukos Clinical Study Site
    Sep 27, 2023

    OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial (Netarsudil 0.02% QD, Timolol maleate 0.5% BID)

    Withdrawn
    • OAG - Open-Angle Glaucoma
    • OHT - Ocular Hypertension
    • Netarsudil 0.02% QD
    • Timolol maleate 0.5% BID
    • (no location specified)
    Mar 17, 2022

    Open Angle Glaucoma, Ocular Hypertension Trial (SDP-133, Lumigan)

    Withdrawn
    • Open Angle Glaucoma
    • Ocular Hypertension
    • (no location specified)
    Nov 18, 2021

    Sturge-Weber Syndrome (SWS), Glaucoma, Glaucoma Congenital Trial in Durham (QLS-101ophthalmic solution 1%, QLS-101ophthalmic

    Active, not recruiting
    • Sturge-Weber Syndrome (SWS)
    • +3 more
    • QLS-101ophthalmic solution 1%
    • QLS-101ophthalmic solution 2%
    • Durham, North Carolina
      Duke Eye Center
    Jul 19, 2022